Decelerating ageing and biological clocks by autophagy by López Otín, Carlos & Kroemer, Guido
Decelerating ageing and biological 
clocks by autophagy 
 
Carlos Lopez-Otín1,2 and Guido Kroemer 2,3,4,5,6* 
 
Ageing is the most important risk factor for the majority of human pathologies. We propose the 
concept that the advancement of the hallmarks of ageing is dictated by several distinct biological clocks 
that can be decelerated by the induction of autophagy. This ‘time dilation’ delays the 
time-dependent manifestation of multiple diseases. 
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Chronological time is measured as a physical constant, whereas biological time is a 
less rigid concept that can be temporarily halted, for instance, by hibernation, cryo- 
preservation, formation of spores or the dauer diapause. Thus, biological model 
systems can age at a variable pace, as a result of the desynchronization of chronologi- 
cal and biological clocks. Distinct intrinsic (for example, genetic) or environmental (for 
example, nutritional) fac- tors may accelerate or decelerate the biological processes that 
cause the progressive decadence and inexorable col- lapse of any living system1. 
Autophagy is one of the most important cytoplasmic recycling mechanisms, which 
delays ageing by acting directly on biological clocks. 
Undoubtedly, time is the most important risk factor for the manifestation of all 
major human pathologies in several major epidemiological categories, including 
neoplastic, cardiovascular and neurodegenerative dis- eases. It is a close-to-trivial 
reality that all these maladies tend to manifest themselves as we age. Even genetically 
determined ailments such as cystic fibrosis and Wilson disease, the two most frequent 
monogenetic diseases in humans, develop over time, and hereditary predispo- sitions 
for cancer, arteriosclerosis, cardiac arrhythmia and neurological diseases materialize 
with age, although precociously with respect to the general population. Nonetheless, 
in biomedical research, time is usually per- ceived — and in fine neglected — as a ‘non-
modifiable’ risk factor, a vision that must change if ‘dilation’ of chronological ageing 
by deceleration of biological clocks is to be considered as a valid therapeutic strategy. 
At the cellular level, the hallmarks of ageing comprise genomic instability, telomere 
attrition, epigenetic altera- tions, loss of proteostasis, deregulated nutrient sensing, 
mitochondrial dysfunction, cellular senescence, stem cell exhaustion and altered 
intercellular communication1. All these hallmarks represent biological clocks, although 
with rather distinct characteristics. Genomic instabi- lity becomes irreversible and 
transmissible as altered nuclear and mitochondrial genomes divide; it ticks like a 
mechanical clock in which each genomic replication constitutes a unit of measurement, 
the amplitude of which can be influenced by the level of external damage and internal 
repair. Telomere attrition is a count-down mechanism in which somatic cells lose 
telomere repeats each time they divide until a critical threshold is reached, unless 
telomerase maintenance mechanisms are acti- vated. Epigenetic alterations more 
accurately reflect bio- logical ageing than chronological ageing, which has led to the 
notion of an ‘epigenetic clock’ that can be decoded by measuring chemical 
modification of DNA and his- tones using ‘omics’ approaches. Loss of proteostasis, in 
particular the ageing-related insufficiency in autophagy (see below), and deregulated 
nutrient sensing, may be profoundly influenced by circadian clocks, given that the 
metabolic responses to both caloric intake and auto- phagy undergo profound daily 
oscillations. Progressive mitochondrial dysfunction, accumulation of senescent cells 
and ever-increasing stem cell exhaustion may be considered as hourglasses that do 
not follow simple internal cues (such as duplications of the genome), or external cues 
(such as circadian oscillations), but instead reflect an irreversible accumulation of 
dysfunctional units (for example, mitochondria or cells), the build- up of which may 
be counteracted by their elimination or replacement1. One of the multiple 
manifestations of altered intercellular communication is the deteriora- tion of 
circadian rhythms, which tend to lose amplitude and precision; this observation 
provides yet another important link between ageing and biological clocks2. 
Reducing temperature in the environment can pro- long the chronological lifespan of 
poikilothermic model organisms (animals whose body temperature varies con- 
siderably), and so does caloric restriction (CR; defined as reduced caloric intake 
without malnutrition). CR decreases energy expenditure and causes a sizeable 
decrease in body temperature, even in warm-blooded animals. This observation has 
been interpreted as ageing being the result of an increase in entropy that intrin- sically 
results from the concatenation of biochemical reactions. However, conflicting with 
this hypothesis, it has been found that intermediate fasting (that is, regu- latory 
periods of fasting followed by ad libitum feeding) and administration of CR mimetics 
(CRMs, which are nutritional or pharmacological agents that mimic the age-
delaying effects of CR3) increase healthspan and lifespan without reducing total 
energy expenditure. 
One of the common consequences of CR and admin- istration of CRMs is the induction 
of macroautophagy (herein referred to as autophagy)1,3–5. This lysosomal degradation 
pathway, which is one of the most impor- tant effectors of proteostasis1, plays a crucial 
role in cellu- lar physiology, including adaptation to metabolic stress, removal of 
deleterious cargo (such as protein aggregates, damaged organelles, including 
dysfunctional mitochon- dria, and intracellular pathogens), cellular recycling during 
differentiation and development, and preven- tion of genomic damage5. Generally, 
these and other functions protect against ageing and against numer- ous diseases, 
including cancer, cardiovascular disorder and neurodegeneration, as well as 
infections4,5, Genetic inhibition of autophagy (by ablation or inactivation of essential 
autophagy-related (ATG) genes) abolishes the lifespan-extending effects of CR and 
CRMs3. Old age, obesity (one of the most important ageing accel- erators) and a series 
of genetically determined diseases, are coupled to inefficient autophagy, locking the 
organ- ism into an inevitable accelerating spiral towards deca- dence1. Conversely, 
genetic manipulations designed to increase autophagy, such as overexpression of Atg5 
orgain-of-function mutation in Bcln1 (the  mammalian orthologue of yeast ATG6), 
are sufficient to extend the healthspan and longevity of mice4,5. 
What, then, are the effects of CR or CRM-induced autophagy on the biological 
clocks that dictate the advancement of ageing? In our opinion, there are four major 
effects of autophagy on age-related processes. First, the autophagy-mediated 
increase in cytoplasmic turnover antagonizes the degeneration of organelles and 
macromolecular complexes. Second, autophagy may improve the mechanisms of 
energy homeostasis, thus facilitating the maintenance of genomic and epigenomic 
stability and improving the acuity of nutrient sensing. Third, autophagy has marked 
anti-inflammatory and immune response-improving effects, thus ameliorating system 
homeostasis. And fourth, thus far neglected, its effects might be related to circadian 
clocks. There is increasing evidence in favour of a bidirectional relation- ship between 
circadian clocks and autophagy2. While circadian rhythms modulate autophagic 
flux, they are themselves influenced by autophagy. The molecular sensors that 
trigger autophagy in response to CR, which include AMPK (responsive to a reduction 
in energy charge reflected by increased AMP and decreased ATP levels), mTOR 
complex 1 (mTORC1) (responsive to depletion of free amino acids), SIRT1 
(responsive to enhanced NAD levels) and EP300 (responsive to dimin- ishing acetyl-
CoA), also regulate circadian clocks2. As a consequence, autophagy is rhythmically 
induced in a circadian clock-dependent manner, while autophagy induction 
influences the circadian clock. For example, inhibition of mTORC1, which activates 
autophagy, slows down the circadian clock, whereas activation of mTORC1 
accelerates it, accentuating the period and amplitude of clock oscillations both in vitro 
and in vivo2. Admittedly, the multiple pathways through which autophagy can 
reduce ageing require further in-depth exploration. However, irrespective of the 
mechanistic uncertainties, the concept that even for humans age- ing is not an 
unalterable process is clearly emerging. Although we remain sceptical with respect 
to the pos- sibility of reversing the arrow of time (and hence reju- venating old 
organisms), it appears increasingly clear that biological clocks can be decelerated to 
dilate time and delay the ageing process. Lifestyle factors (such as CR, nutritional 
uptake of CRMs and exercise), as well as autophagy-stimulating drugs (including 
pharmaco- logical CRMs) might be taken advantage of to combat ageing and any type 
of age-related, time-dependent dis- ease. Thus, the goal of time-dilating interventions 
should be to break the link between chronological and biologi- cal time, to delay (and 
possibly suppress) the manifes- tation of ageing-related diseases to extend 
healthspan. It remains to be determined whether distinct autophagy- inducing strategies 
might be advantageously combined and whether autophagy stimulation is the sole 
strategy for obtaining such a broad effect. 
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